(Q34116094)

31 July 2017

1 reference

title

Calpain-dependent proteolysis of NF2 protein: involvement in schwannomas and meningiomas (English)

1 reference

31 July 2017

1 reference

Kimura Y

1

1 reference

PubMed ID

11132929

31 July 2017

Saya H

series ordinal

2

1 reference

PubMed ID

11132929

31 July 2017

Nakao M

series ordinal

3

1 reference

31 July 2017

1 September 2000

1 reference

31 July 2017

1 reference

31 July 2017

20

1 reference

31 July 2017

3

1 reference

31 July 2017

153-160

1 reference

Neurofibromatosis 2: loss of merlin's protective spell

31 July 2017

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1789.2000.00326.X

Neurofibromatosis 2 (bilateral acoustic neurofibromatosis).

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1789.2000.00326.X

Alteration in a new gene encoding a putative membrane-organizing protein causes neuro-fibromatosis type 2

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1789.2000.00326.X

A novel moesin-, ezrin-, radixin-like gene is a candidate for the neurofibromatosis 2 tumor suppressor.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1789.2000.00326.X

The involvement of calpain-dependent proteolysis of the tumor suppressor NF2 (merlin) in schwannomas and meningiomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1789.2000.00326.X

Ocular abnormalities in neurofibromatosis 2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1789.2000.00326.X

Common pathogenetic mechanism for three tumor types in bilateral acoustic neurofibromatosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1789.2000.00326.X

Neurofibromatosis 2: clinical and DNA linkage studies of a large kindred

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1789.2000.00326.X

ERM (ezrin/radixin/moesin) family: from cytoskeleton to signal transduction

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1789.2000.00326.X

Ezrin contains cytoskeleton and membrane binding domains accounting for its proposed role as a membrane-cytoskeletal linker

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1789.2000.00326.X

Neurofibromatosis 2 tumour suppressor schwannomin interacts with betaII-spectrin

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1789.2000.00326.X

The Nf2 tumor suppressor gene product is essential for extraembryonic development immediately prior to gastrulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1789.2000.00326.X

Mice heterozygous for a mutation at the Nf2 tumor suppressor locus develop a range of highly metastatic tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1789.2000.00326.X

Ruffling membrane, stress fiber, cell spreading and proliferation abnormalities in human Schwannoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1789.2000.00326.X

A genetic study of type 2 neurofibromatosis in the United Kingdom. I. Prevalence, mutation rate, fitness, and confirmation of maternal transmission effect on severity

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1789.2000.00326.X

Impairment of cell adhesion by expression of the mutant neurofibromatosis type 2 (NF2) genes which lack exons in the ERM-homology domain

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1789.2000.00326.X

The neurofibromatosis type 2 gene is inactivated in schwannomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1789.2000.00326.X

Alternative splicing of the NF2 gene and its mutation analysis of breast and colorectal cancers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1789.2000.00326.X

Mutations in transcript isoforms of the neurofibromatosis 2 gene in multiple human tumour types.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1789.2000.00326.X

High frequency of inactivating mutations in the neurofibromatosis type 2 gene (NF2) in primary malignant mesotheliomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1789.2000.00326.X

Loss of merlin expression in sporadic meningiomas, ependymomas and schwannomas.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1789.2000.00326.X

Structure and physiological function of calpains

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1789.2000.00326.X

Brain fodrin: substrate for calpain I, an endogenous calcium-activated protease

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1789.2000.00326.X

Expression in Escherichia coli, phosphorylation with cAMP-dependent protein kinase and proteolysis by calpain of a 71-kDa domain of human endothelial actin binding protein.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1789.2000.00326.X

Proteolysis of tubulin and microtubule-associated proteins 1 and 2 by calpain I and II. Difference in sensitivity of assembled and disassembled microtubules.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1789.2000.00326.X

The HPV-16 E6 and E6-AP complex functions as a ubiquitin-protein ligase in the ubiquitination of p53

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1789.2000.00326.X

Decreased levels of the cell-cycle inhibitor p27Kip1 protein: prognostic implications in primary breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1789.2000.00326.X

Increased proteasome-dependent degradation of the cyclin-dependent kinase inhibitor p27 in aggressive colorectal carcinomas.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1789.2000.00326.X

Predominant occurrence of somatic mutations of theNF2 gene in meningiomas and schwannomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1789.2000.00326.X

Evidence for the complete inactivation of the NF2 gene in the majority of sporadic meningiomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1789.2000.00326.X

10.1046/J.1440-1789.2000.00326.X

21 January 2018

Identifiers

DOI

1 reference

31 July 2017

1 reference

PubMed ID

11132929